| Taiwan Time | Topic | Speaker | Moderator |
|---|---|---|---|
| 8:30-8:35 | Opening Remarks: Suporn Treepongkaruna (President of APPSPGHAN) | ||
| 8:35-8:40 | Welcome Message: Huey-Ling Chen (President of TSPGHAN) | ||
| Impact of Covid-19 on Hepatology Practice | |||
| 8:40-9:00 | Special Lecture Impact of Covid-19 on Pediatric Liver Transplantation |
Mercedes Martinez (USA) |
Suporn Treepongkaruna (President of APPSPGHAN) |
| 9:00-9:10 | Discussion
Suporn Treepongkaruna
(President of APPSPGHAN) |
||
| 9:10-10:40 | Cholestatic and Metabolic Liver Diseases | ||
| 9:10-9:30 | Novel Treatment in Cholestatic Diseases (IBAT Inhibitor Trials) | Saul J. Karpen (USA) |
Huey-Ling Chen (President of TSPGHAN) Kazuhiko Bessho (Japan) |
| 9:30-9:50 | Bile Acid Metabolic Disorders in Asia-Pacific Region-the Importance of Early Diagnosis | Tatsuki Mizuochi (Japan)
Huey-Ling Chen
(President of TSPGHAN) Kazuhiko Bessho (Japan) |
|
| 9:50-10:20 | Keynote Lecture Recent Advances in the Diagnosis and Prognosis Prediction of Biliary Atresia and Cholestatic Liver Diseases |
Jorge A Bezerra (USA)
Huey-Ling Chen
(President of TSPGHAN) Kazuhiko Bessho (Japan) |
|
| 10:20-10:40 | Discussion
Huey-Ling Chen
(President of TSPGHAN) Kazuhiko Bessho (Japan) |
||
| 10:40-12:20 | NAFLD and Gut Liver Axis | ||
| 10:40-11:00 | Therapeutic Updates of Pediatric NAFLD | Stavra Xanthakos (USA) |
Way Seah Lee (Malaysia) Chun Yan Yeung (Taiwan) |
| 11:00-11:20 | NAFLD from Asian Perspectives | Yu-Cheng Lin (Taiwan)
Way Seah Lee
(Malaysia) Chun Yan Yeung (Taiwan) |
|
| 11:20-11:40 | Assessment of Pediatric NAFLD | Voranush Chongsrisawat (Thailand)
Way Seah Lee
(Malaysia) Chun Yan Yeung (Taiwan) |
|
| 11:40-12:00 | Microbiome, Fatty Liver, and Pediatric Health | Yen-Hsuan Ni (Taiwan)
Way Seah Lee
(Malaysia) Chun Yan Yeung (Taiwan) |
|
| 12:00-12:20 | Discussion
Way Seah Lee
(Malaysia) Chun Yan Yeung (Taiwan) |
||
| Taiwan Time | Topic | Speaker | Moderator |
|---|---|---|---|
| 12:20-13:50 | Viral Hepatitis: Toward Global Elimination of Hepatitis | ||
| 12:20-12:50 | Keynote Lecture The Impact of Neonatal Immunization and Maternal Antiviral Treatment on Mother-to-Infant Transmission of HBV Infection |
Mei-Hwei Chang (Taiwan) |
Winita Hardikar (Australia) Yao-Jong Yang (Taiwan) |
| 12:50-13:10 | Updates of HBV Treatment in Children | Ayano Inui (Japan)
Winita Hardikar
(Australia) Yao-Jong Yang (Taiwan) |
|
| 13:10-13:30 | A Practical Guide to Treating Paediatric HCV in the Asia-Pacific Region Now | Winita Hardikar (Australia)
Winita Hardikar
(Australia) Yao-Jong Yang (Taiwan) |
|
| 13:30-13:50 | Discussion
Winita Hardikar
(Australia) Yao-Jong Yang (Taiwan) |
||
| 13:50-15:10 | Advances in Pediatric Liver Disease Management | ||
| 13:50-14:10 | Wilson Disease: Updates in Diagnosis, Treatment, and Disease Monitoring | Jae Sung Ko (Korea) |
Jae Sung Ko (Korea) Jia-Feng Wu (Taiwan) |
| 14:10-14:30 | Liver Transplantation in Babies Below 5 kg | Anupam Sibal (India)
Jae Sung Ko
(Korea) Jia-Feng Wu (Taiwan) |
|
| 14:30-14:50 | Long-Term Follow-up of FIC1 and BSEP Deficiency Patients-the NAPPED Consortium | Henkjan J Verkade (Netherland)
Jae Sung Ko
(Korea) Jia-Feng Wu (Taiwan) |
|
| 14:50-15:10 | Discussion
Jae Sung Ko
(Korea) Jia-Feng Wu (Taiwan) |
||
| 15:10 |
Closing Remarks:
Suporn Treepongkaruna (President of APPSPGHAN)
Huey-Ling Chen (President of TSPGHAN) |
||